Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Anlotinib for Alveolar Soft Part Sarcoma
Recruiting1 awardPhase 3
Nashville, Tennessee
This trial is currently recruiting patients with alveolar soft part sarcoma only and is no longer recruiting patients with synovial sarcoma or leiomyosarcoma.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service